The main route of Epstein Barr virus (EBV) transmission is the oral route, through the saliva that contains infected epithelial cells. Also, it can spread through blood transfusion and organ transplantations. Approximately 95% of adults harbour EBV and cause 1% of all cancers, and there is no consistent difference in seroprevalence by sex in children. Although, antibody titers may be higher in females.
The Epstein Barr virus (EBV) can get transmitted easily amongst humans through bodily fluids. The most commonly occurring infection is known as mononucleosis or the “ kissing disease”, but it can also travel via blood and semen. The virus will only get transmitted if it lies within the host in an active state, in cases where the virus lies in an inactive state, the transmission process stops unless it gets reactivated. Therefore, the virus can be transmitted both in the incubation period (4-7 weeks) as well as the period during the occurrence of symptoms.
Get FREE sample copy at:
https://www.delveinsight.com/sample-request/epstein-barr-virus-ebv-market
The Epstein Barr virus (EBV) market report also covers emerging drugs, current treatment practices, Epstein Barr virus (EBV) market share of the individual therapies, current and forecasted Epstein Barr virus (EBV) Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Epstein Barr virus (EBV) treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Key Benefits of Epstein Barr virus (EBV) Market Report
-
Epstein Barr virus (EBV) market report provides an in-depth analysis of Epstein Barr virus (EBV) Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets, i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
-
The Epstein Barr virus (EBV) market report will help in developing business strategies by understanding the Epstein Barr virus (EBV) Market trends & developments, key players, and future market competition that will shape and drive the Epstein Barr virus (EBV) market in the upcoming years.
-
The Epstein Barr virus (EBV) market report covers the Epstein Barr virus (EBV) current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Epstein Barr virus (EBV) market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Epstein Barr virus (EBV) Market
The Epstein Barr virus (EBV) market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Epstein Barr virus (EBV) market trends by analysing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Epstein Barr virus (EBV) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Epstein Barr virus (EBV) Epidemiology
The Epstein Barr virus (EBV) epidemiology section covers insights about the historical and current Epstein Barr virus (EBV) patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Epstein Barr virus (EBV) Drugs Uptake and Key Market Players
The Epstein Barr virus (EBV) Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Epstein Barr virus (EBV) market or expected to get launched in the market during the study period. The analysis covers Epstein Barr virus (EBV) market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Epstein Barr Virus Companies:
Atara Biotherapeutics
Cullinan Oncology
China Immunotech Biotechnology
And many others.
Epstein Barr Virus Therapies covered in the report include:
Tabelecleucel
VK-2019
EBV-TCR-T cells
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Epstein Barr virus (EBV) Competitive Intelligence Analysis
4. Epstein Barr virus (EBV) Market Overview at a Glance
5. Epstein Barr virus (EBV) Disease Background and Overview
6. Epstein Barr virus (EBV) Patient Journey
7. Epstein Barr virus (EBV) Epidemiology and Patient Population
8. Epstein Barr virus (EBV) Treatment Algorithm, Current Treatment, and Medical Practices
9. Epstein Barr virus (EBV) Unmet Needs
10. Key Endpoints of Epstein Barr virus (EBV) Treatment
11. Epstein Barr virus (EBV) Marketed Products
12. Epstein Barr virus (EBV) Emerging Therapies
13. Epstein Barr virus (EBV) Seven Major Market Analysis
14. Attribute Analysis
15. Epstein Barr virus (EBV) Market Outlook (7 major markets)
16. Epstein Barr virus (EBV) Access and Reimbursement Overview
17. KOL Views on the Epstein Barr virus (EBV) Market.
18. Epstein Barr virus (EBV) Market Drivers
19. Epstein Barr virus (EBV) Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Related Reports By DelveInsight
Epstein Barr virus (EBV) Epidemiology Forecast
DelveInsight’s Epstein Barr virus (EBV) – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Epstein Barr virus (EBV) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Epstein Barr virus (EBV) Pipeline Insights
Epstein Barr virus (EBV) Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Epstein Barr virus (EBV) market.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
Country: United States
Website: www.delveinsight.com/